On this page
Short answer Aducanumab and dependence: what to know Common questions Related questions Sources**No, aducanumab-avwa injection is not known to be addictive.**
Aducanumab-avwa, sold as Aduhelm, is an antibody treatment that targets amyloid plaques in Alzheimer's disease. You are not expected to develop cravings or withdrawal symptoms from it. Its scheduled dose increases were intended to reduce treatment risks, not to manage addiction or dependence. The manufacturer discontinued Aduhelm, so ask your clinician about available treatment options. If you previously received it, keep any recommended follow-up appointments.
Aducanumab and dependence: what to know
Common questions
Is Aducanumab-avwa Injection addictive?
No, aducanumab-avwa injection (Aduhelm) is not known to cause addiction, cravings, or physical dependence. It is an antibody that targets amyloid plaques in Alzheimer's disease. Receiving repeated infusions or gradually increasing the dose does not mean you are addicted. Its main safety concerns include brain swelling or bleeding and allergic reactions, which require medical monitoring. The manufacturer discontinued Aduhelm. If you previously received it, ask your clinician about follow-up care and available alternatives; do not assume new symptoms are withdrawal.